glycosylase gene was UL2, which is at the left end of the long unique (UL) segment of the genome (see Fig. 1 ). We have now analysed this gene by insertional mutagenesis. The plasmid pGX23 (supplied by V. G. Preston, MRC Virology Unit) contains the HSV-1 BamHI e fragment, in which gene UL2 resides. UL2 was mutagenized by inserting an XbaI fragment of the plasmid pFJ3 (supplied by F. Rixon and J. McLauchlan, MRC Virology Unit) into the unique XbaI site in the UL2 gene. This fragment contained the Escherichia colilacZ gene (encoding fl-galactosidase) under the direction of the simian virus 40 early promoter. This gave rise to the plasmid pJM3. pJM3 DNA was digested with BstEII, which cuts the plasmid at three sites, each of which is at least 4 kbp from gene UL2. This DNA was cotransfected with HSV-1 strain 17 DNA onto confluent monolayers of BHK C13 cells in 50 mm plates using the calcium phosphate technique followed by a dimethyl sulphoxide boost (Stow & Wilkie, 1976) . The plates were overlaid with Glasgow modified Eagle's medium (GMEM) which contained 100 units/ml penicillin, 100 ~tg/ml streptomycin, 1.5~ methyl cellulose and was supplemented with 5~ calf serum. The plates were incubated at 37 °C for 2 to 3 days, until plaques appeared. The medium was then removed and the plates were overlaid with GMEM containing 0"64~o Noble agar and 1.5 mM-5-bromo-4-chloro-3-indolyl fl-D-galactopyranoside, a chromogenic substrate for flgalactosidase. After overnight incubation, plaques formed by recombinant progeny virus expressing the fl-galactosidase gene turned blue. These blue plaques were picked and purified to homogeneity by four successive rounds of plaque purification. An elite stock, made from a single blue plaque picked from the fourth round of purification, was designated in 1601, and used in all subsequent experiments.
The genomic structure of the recombinant in1601 was examined by restriction analysis of virus DNA with the enzymes XbaI, BamHI and BglII, as described by Lonsdale (1979) (data not shown). This analysis indicated that the insert was in the expected location in the viral genome, and no other changes were seen in inl601 DNA.
A one-step growth curve experiment was performed on inl601 and the wild-type (wt) parent virus. Confluent monolayers of BHK C 13 cells on 35 mm plates were infected with either wt or inl601 virus at an m.o.i, of 5 p.f.u./cell and left to incubate for 1 h. The plates were then washed twice with GMEM without serum, and overlaid with 1.5 ml of GMEM supplemented with 5~ tryptose phosphate and 10~o calf serum (ETC10). Plates were harvested at l, 2, 3, 4, 6, 8, 10, 12, 21 and 25 h post-infection (p.i.) by scraping into the medium. The harvests were disrupted ultrasonically and titrated on 50 mm plates of confluent BHK C13 cells. Fig. 2 shows the onestep growth profiles of the wt parent and in1601 progeny virus. The two isolates had very similar growth characteristics, with both curves being as expected for HSV-1 wt. This is consistent with the observation that in1601 formed plaques and grew as well as the wt throughout the rounds of purification (data not shown).
Extracts were made and assayed for uracil-DNA glycosylase activity by measuring the release of radioactivity from DNA containing [3H]uracil as described by Caradonna & Cheng (1980) . Plates (90 mm) of confluent monolayers of BHK C 13 cells were either mock-infected or infected with wt or inl601 virus at an m.o.i, of 10 p.f.u./cell and harvested at 3, 6, 9 and 12 h p.i. The extracts were also assayed for viral DNA polymerase activity (Keir et al., 1966) and alkaline exonuclease activity (Francke et al., 1978) . The results of the uracil-DNA glycosylase assay (Fig.  3a) show that there is no significant glycosylase activity associated with inl601 in comparison with the levels seen with wt and the mock-infected control. Checks were made for the wt enzyme that the released radioactivity was actually in uracil, as tested by thin-layer chromatography. As controls for the efficiency of the infections, viral DNA polymerase and alkaline exonuclease activities were measured in all the extracts, and the results are shown in Fig. 3 (b,c) . These figures show that in1601 induces levels of both viral D NA polymerase and alkaline exonuclease activities which are comparable to those of the wt, the mock-infected levels of both enzymes being negligible.
In order to determine how the gene was regulated, i.e. whether it was an early or late gene, infections were performed on BHK C13 cells with wt virus in the presence or absence of 300 I~g/ml phosphonoacetic acid (PAA), which inhibits viral DNA synthesis in wt HSV-1 (Shipkowitz et al., 1973) . Confluent monolayers were incubated in ETC10 supplemented with 300 l.tg/ml PAA for 1 h before being infected with virus at an m.o.i, of 10 p.f.u./cell in the presence or absence of 300 ~tg/ml PAA. The plates were incubated for 1 h before being overlaid with ETC10 containing 300 ~tg/ml PAA. The cells were harvested at 24 h p.i. and extracts were prepared and assayed for uracil-DNA glycosylase, viral DNA polymerase and alkaline exonuclease activities as previously described. There was no significant difference in the levels of enzyme activity between cells infected in the presence or absence of PAA (data not shown), indicating that UL2 is an early gene.
Although the results presented here show that inactivation of gene UL2 leads to a complete loss of glycosylase activity, this in itself cannot be taken as proof that this gene encodes the . Extracts were prepared as described by Caradonna & Cheng (1981) . (a) Uracil DNA glycosylase activity of extracts made at 3, 6, 9 and 12 h p.i. The assay was performed under the conditions described by Caradonna & Cheng (1980) , using a 1 in 10 dilution of the extracts. (b) Time course for the alkaline exonuclease activity, performed at pH 9 and using radiolabelled BHK DNA as described by Francke et al. (1978) . Extracts were assayed at a dilution of 1 in 10 and acid-soluble radioactivity was measured after incubation at 37 °C for 1 h. (c) Viral DNA polymerase activity through the time course. DNA polymerase activity was measured in undiluted cell extracts essentially by the method of Keir et al. (1966) but using activated calf thymus DNA (Weissbach et al., 1973) as template and with a KC1 concentration of 200 mM. enzyme. The UL2 gene could, in principle, encode a regulator of the glycosylase. However, in the light of the mapping data already available (Caradonna et al., 1987) , it seems essentially certain that the UL2 gene codes for the glycosylase. Gene UL2 has counterparts in the other herpesviruses whose genomes have been sequenced. These are gene 59 in varicella-zoster virus (VZV) (Davison & Scott, 1986; Davison & Taylor, 1987) and BKRF3 in Epstein Barr virus (EBV) (Baer et al., 1984; . The amino acid sequences of all three genes are notably conserved, especially towards their 3' termini. Thus, although the gene is dispensable for growth of HSV-1 in tissue culture its function may be important for survival of the viruses in vivo. pointed out the presence of two possible initiation codons for the UL2 open reading frame (ORF). The first opens an ORF encoding a polypeptide of 334 amino acids with a predicted M, of 36 300, and the second opens an ORF encoding a polypeptide of 244 amino acids with a predicted Mr of 27 300. From comparisons of the amino acid sequences of UL2 with the homologues in VZV and EBV the second candidate initiation codon may be more likely.
Since this work was completed, Varshney et al. (1988) have published the sequence of the E. coli uracil-DNA glycosylase gene and show that it encodes a protein of 229 residues with an Mr of 25 664. We have compared the amino acid sequence of this protein with the amino acid sequence of HSV-I UL2 and its homologues in VZV and EBV. As shown in Fig. 4 , there are several regions of complete identity (see consensus) and there are other regions which have partial identity between three of the four sequences. The level of similarity between the herpesvirus sequences and the E. coli sequence is very striking, and confirms that UL2 does encode the uracil-DNA glycosylase enzyme.
J.M. is in receipt of a Medical Research Council postgraduate studentship.
